Our previous studies indicated that anesthesia/surgery could aggravate cognitive impairment and tau pathology in female 5XFAD transgenic (Tg) mice. However, it is unknown whether there are sex differences in the susceptibility of developing postoperative cognitive dysfunction in 5XFAD Tg mice.
Objective:
In this study, we aim to determine whether anesthesia/surgery can have different effects on female and male 5XFAD Tg mice, and to explore the underpinning mechanisms.
Methods:
The mice received abdominal surgery under isoflurane anesthesia. Morris water maze was used to assess the cognitive function. Hippocampal levels of p-tau (AT8), p-IRS1 (Ser612), IRS1, p-GSK3β (Tyr216), and p-GSK3β (Ser9) at postoperative day 1 were evaluated by western blot assays.
Results:
Anesthesia/surgery exaggerated cognitive impairment and tau pathology in female, but not male 5XFAD Tg mice. The anesthesia/surgery led to elevated hippocampus protein levels of p-IRS1 (Ser612)/IRS1 ratio and p-GSK3β (Tyr216) and reduced hippocampus protein levels of p-GSK3β (Ser9) in female, but not male 5XFAD Tg mice.
Conclusions:
This study demonstrated that female 5XFAD Tg mice were more susceptible to anesthesia/surgery-induced cognitive deterioration and tau pathology aggravation, potentially due to female-specific brain insulin resistance.
2023 Alzheimer’s disease facts and figures. Alzheimers Dement2023; 19: 1598–1695.
2.
BourquardT, LeeK, Al-RamahiI, et al. Functional variants identify sex-specific genes and pathways in Alzheimer’s disease. Nat Commun2023; 14: 2765.
3.
FerrettiMT, IulitaMF, CavedoE, et al. Sex differences in Alzheimer disease – the gateway to precision medicine. Nat Rev Neurol2018; 14: 457–469.
4.
ZhuD, MontagneA and
ZhaoZ. Alzheimer’s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci2021; 78: 4907–4920.
5.
ShenY, ZhangT, ZhangY, et al. Stress granules modulate SYK to cause tau-associated neurocognitive deterioration in 5XFAD mouse after anesthesia and surgery. Front Aging Neurosci2021; 13: 718701.
6.
ZhangJ, ZhangT, WangY, et al. Gα13-mediated signaling cascade is related to the tau pathology caused by anesthesia and surgery in 5XFAD transgenic mice. J Alzheimers Dis2023; 93: 545–560.
7.
MittalK and
KatareDP. Shared links between type 2 diabetes mellitus and Alzheimer’s disease: A review. Diabetes Metab Syndr2016; 10: S144–S149.
8.
De FeliceFG, GonçalvesRA and
FerreiraST. Impaired insulin signalling and allostatic load in Alzheimer disease. Nat Rev Neurosci2022; 23: 215–230.
9.
KellarD and
CraftS. Brain insulin resistance in Alzheimer’s disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol2020; 19: 758–766.
10.
HamzéR, DelangreE, ToluS, et al. Type 2 diabetes mellitus and Alzheimer’s disease: shared molecular mechanisms and potential common therapeutic targets. Int J Mol Sci2022; 23: 15287.
11.
BlázquezE, Hurtado-CarneiroV, LeBaut-AyusoY, et al. Significance of brain glucose hypometabolism, altered insulin signal transduction, and insulin resistance in several neurological diseases. Front Endocrinol (Lausanne)2022; 13: 873301.
12.
FronzaMG, AlvesD, PraticòD, et al. The neurobiology and therapeutic potential of multi-targeting β-secretase, glycogen synthase kinase 3β and acetylcholinesterase in Alzheimer’s disease. Ageing Res Rev2023; 90: 102033.
13.
WagnerL, VeitR, KüblerC, et al. Brain insulin responsiveness is linked to age and peripheral insulin sensitivity. Diabetes Obes Metab2023; 25: 2171–2180.
14.
ZhouC, DongC, XieZ, et al. Sex-specific associations between diabetes and dementia: the role of age at onset of disease, insulin use and complications. Biol Sex Differ2023; 14: 9.
15.
MaffioliE, MurtasG, RabattoniV, et al. Insulin and serine metabolism as sex-specific hallmarks of Alzheimer’s disease in the human hippocampus. Cell Rep2022; 40: 111271.
16.
YasudaY, FukushimaY, KanekiM, et al. Anesthesia with propofol induces insulin resistance systemically in skeletal and cardiac muscles and liver of rats. Biochem Biophys Res Commun2013; 431: 81–85.
17.
KimSP, BroussardJL and
KolkaCM. Isoflurane and sevoflurane induce severe hepatic insulin resistance in a canine model. PLoS One2016; 11: e0163275.
18.
OakleyH, ColeSL, LoganS, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer’s disease mutations: potential factors in amyloid plaque formation. J Neurosci2006; 26: 10129–10140.
19.
VorheesCV and
WilliamsMT. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc2006; 1: 848–858.
20.
ZhangC, ZhangY, ShenY, et al. Anesthesia/surgery induces cognitive impairment in female Alzheimer’s disease transgenic mice. J Alzheimers Dis2017; 57: 505–518.
21.
OhES, SieberFE, LeoutsakosJ-M, et al. Sex differences in hip fracture surgery: preoperative risk factors for delirium and postoperative outcomes. J Am Geriatr Soc2016; 64: 1616–1621.
22.
StanleyME, KantS, RakerC, et al. Effect of patient sex on neurocognitive decline after cardiac surgery. J Am Coll Surg2023; 236: 1112–1124.
23.
HogueCW, LillieR, HersheyT, et al. Gender influence on cognitive function after cardiac operation. Ann Thoracic Surg2003; 76: 1119–1125.
24.
BuckleyRF, ScottMR, JacobsHIL, et al. Sex mediates relationships between regional tau pathology and cognitive decline. Ann Neurol2020; 88: 921–932.
25.
WangX, SundermannEE, BuckleyRF, et al. Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD. Alzheimers Dement2024; 20: 25–33.
26.
SalonerR, VandeVredeL, AskenBM, et al. Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults. Alzheimers Dement2024; 20: 376–387.
27.
HanF, ZhaoJ and
ZhaoG. Prolonged volatile anesthetic exposure exacerbates cognitive impairment and neuropathology in the 5xFAD mouse model of Alzheimer’s disease. J Alzheimers Dis2021; 84: 1551–1562.
28.
PilcherH. Alzheimer’s disease could be “type 3 diabetes”. Lancet Neurol2006; 5: 388–389.
29.
MartinL, LatypovaX, WilsonCM, et al. Tau protein kinases: involvement in Alzheimer’s disease. Ageing Res Rev2013; 12: 289–309.
30.
SayasCL and
ÁvilaJ. GSK-3 and tau: a key duet in Alzheimer’s disease. Cells2021; 10: 721.
31.
HeX, LongG, QuanC, et al. Insulin resistance predicts postoperative cognitive dysfunction in elderly gastrointestinal patients. Front Aging Neurosci2019; 11: 197.
32.
MaoY-F, GuoZ, ZhengT, et al. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice. Aging Cell2016; 15: 893–902.
33.
HölscherC. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer’s disease. Alzheimers Dement2014; 10: S33–S37.
34.
NovakV, MilbergW, HaoY, et al. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care2014; 37: 751–759.
35.
JosephJJ and
GoldenSH. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann N Y Acad Sci2017; 1391: 20–34.
36.
ValentinoRJ, Van BockstaeleE and
BangasserD. Sex-specific cell signaling: the corticotropin-releasing factor receptor model. Trends Pharmacol Sci2013; 34: 437–444.
